Repligen
RGEN
184 hedge funds and large institutions have $1.37B invested in Repligen in 2017 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 78 increasing their positions, 55 reducing their positions, and 29 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 55
2% less capital invested
Capital invested by funds: $1.4B → $1.37B (-$22.8M)
7% less call options, than puts
Call options by funds: $4.44M | Put options by funds: $4.78M
3% less funds holding
Funds holding: 190 → 184 (-6)
10.67% less ownership
Funds ownership: 97.56% → 86.89% (-11%)
21% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$29.1M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$26.9M |
| 3 |
State Street
Boston,
Massachusetts
|
+$19.9M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$9.03M |
| 5 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$7.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.1M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$11.2M |
| 3 |
CM
Castleark Management
Chicago,
Illinois
|
-$4.91M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$4.17M |
| 5 |
Renaissance Technologies
New York
|
-$4.07M |
RGEN Hedge Fund Activity: Q4 2017 in Review
184 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q4 2017, worth a combined $1.37B — down 1.6% from $1.4B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of RGEN and 23 opened new positions — a net loss of 6 holders — while 55 trimmed existing stakes and 78 added.
The largest buyer was Mackenzie Financial, adding an estimated $29.1M. The largest seller was Fidelity Investments, cutting an estimated $20.1M.
- 184 institutional investors held Repligen (RGEN) as of Q4 2017, down from 190 in Q3 2017.
- Funds reported $1.37B of Repligen stock for Q4 2017, down 1.6% quarter-over-quarter.
- 23 funds opened new Repligen positions in Q4 2017 and 29 closed out, a net change of -6 holders.
- The largest Repligen buyer in Q4 2017 was Mackenzie Financial, an estimated $29.1M added.
- The largest Repligen seller in Q4 2017 was Fidelity Investments, an estimated $20.1M sold.
Based on aggregated 13F filings for Q4 2017.